Perspective Therapeutics (CATX) Free Cash Flow (2010 - 2026)
Perspective Therapeutics recorded quarterly Free Cash Flow of -$31.5 million in Q1 2026, down 27.36% quarter-over-quarter from -$24.7 million in Q4 2025, and down 45.75% year-over-year from -$58.0 million in Q1 2025.
Perspective Therapeutics' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$31.5 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 45.75% year-over-year to -$31.5 million; the TTM figure through Mar 2026 stood at -$92.5 million (up 14.47% YoY), while the FY2025 annual figure was -$82.6 million, down 13.63% from the prior year.
- Free Cash Flow came in at -$31.5 million for Q1 2026 at Perspective Therapeutics, down from -$24.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $13.8 million in Q1 2024 to a low of -$81.0 million in Q4 2024.
- A 5-year average of -$14.0 million and a median of -$9.9 million in 2023 frame the typical range for Free Cash Flow.
- On a YoY basis, Free Cash Flow climbed as much as 239.54% in 2024 and fell as far as 790.36% in 2024.
- Perspective Therapeutics' Free Cash Flow stood at -$6.2 million in 2022, then sank by 45.86% to -$9.1 million in 2023, then tumbled by 790.36% to -$81.0 million in 2024, then soared by 69.49% to -$24.7 million in 2025, then slipped by 27.36% to -$31.5 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$31.5 million, -$24.7 million, and -$16.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | -31.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.47 Mn |
| Mar 31, 2026 | -31.47 Mn |
| Dec 31, 2025 | -24.71 Mn |
| Dec 31, 2025 | -24.71 Mn |
| Sep 30, 2025 | -16.33 Mn |
| Sep 30, 2025 | -16.33 Mn |
| Jun 30, 2025 | -19.99 Mn |
| Jun 30, 2025 | -19.99 Mn |
| Mar 31, 2025 | -21.59 Mn |
| Mar 31, 2025 | -21.59 Mn |
| Dec 31, 2024 | -81.00 Mn |
| Dec 31, 2024 | -81.00 Mn |
| Sep 30, 2024 | 13.43 Mn |
| Sep 30, 2024 | 13.43 Mn |
| Jun 30, 2024 | -18.99 Mn |
| Jun 30, 2024 | -18.99 Mn |
| Mar 31, 2024 | 13.85 Mn |
| Mar 31, 2024 | 13.85 Mn |
| Dec 31, 2023 | -9.10 Mn |
| Dec 31, 2023 | -9.10 Mn |
| Sep 30, 2023 | -11.08 Mn |
| Sep 30, 2023 | -11.08 Mn |
| Jun 30, 2023 | -7.89 Mn |
| Jun 30, 2023 | -7.89 Mn |
| Mar 31, 2023 | -9.92 Mn |
| Mar 31, 2023 | -9.92 Mn |
| Dec 31, 2022 | -6.24 Mn |
| Dec 31, 2022 | -6.24 Mn |
| Sep 30, 2022 | -1.85 Mn |
| Sep 30, 2022 | -1.85 Mn |
| Jun 30, 2022 | -4.45 Mn |
| Jun 30, 2022 | -4.45 Mn |
| Mar 31, 2022 | -1.45 Mn |
| Mar 31, 2022 | -1.45 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Sep 30, 2021 | -2.14 Mn |
| Sep 30, 2021 | -2.14 Mn |
| Mar 31, 2021 | -714,000.00 |
| Mar 31, 2021 | -714,000.00 |
| Dec 31, 2020 | -820,000.00 |
| Dec 31, 2020 | -820,000.00 |
| Sep 30, 2020 | -451,000.00 |
| Sep 30, 2020 | -451,000.00 |
| Jun 30, 2020 | -873,000.00 |
| Jun 30, 2020 | -873,000.00 |
| Mar 31, 2020 | -906,000.00 |
| Mar 31, 2020 | -906,000.00 |
| Dec 31, 2019 | -1.38 Mn |
| Dec 31, 2019 | -1.38 Mn |
| Sep 30, 2019 | -751,000.00 |
| Sep 30, 2019 | -751,000.00 |
| Jun 30, 2019 | -1.08 Mn |
| Jun 30, 2019 | -1.08 Mn |
| Mar 31, 2019 | -1.47 Mn |
| Mar 31, 2019 | -1.47 Mn |
| Dec 31, 2018 | -1.23 Mn |
| Dec 31, 2018 | -1.23 Mn |
| Sep 30, 2018 | -1.73 Mn |
| Sep 30, 2018 | -1.73 Mn |
| Jun 30, 2018 | -1.55 Mn |
| Jun 30, 2018 | -1.55 Mn |
| Mar 31, 2018 | -1.16 Mn |
| Mar 31, 2018 | -1.16 Mn |
| Dec 31, 2017 | -1.62 Mn |
| Dec 31, 2017 | -1.62 Mn |
| Sep 30, 2017 | -1.72 Mn |
| Sep 30, 2017 | -1.72 Mn |
| Jun 30, 2017 | -1.47 Mn |
| Jun 30, 2017 | -1.47 Mn |
| Mar 31, 2017 | -1.54 Mn |
| Mar 31, 2017 | -1.54 Mn |
| Dec 31, 2016 | -1.75 Mn |
| Dec 31, 2016 | -1.75 Mn |
| Sep 30, 2016 | -1.50 Mn |
| Sep 30, 2016 | -1.50 Mn |
| Jun 30, 2016 | -1.61 Mn |
| Jun 30, 2016 | -1.61 Mn |
| Mar 31, 2016 | -981,000.00 |
| Mar 31, 2016 | -981,000.00 |
| Dec 31, 2015 | -842,000.00 |
| Dec 31, 2015 | -842,000.00 |
| Sep 30, 2015 | -1.11 Mn |
| Sep 30, 2015 | -1.11 Mn |
| Jun 30, 2015 | -629,536.00 |
| Jun 30, 2015 | -629,536.00 |
| Mar 31, 2015 | -1.16 Mn |
| Mar 31, 2015 | -1.16 Mn |
| Jun 30, 2014 | -991,720.00 |
| Jun 30, 2014 | -991,720.00 |
| Mar 31, 2014 | -503,109.00 |
| Mar 31, 2014 | -503,109.00 |
| Dec 31, 2013 | -858,359.00 |
| Dec 31, 2013 | -858,359.00 |
| Sep 30, 2013 | -894,062.00 |
| Sep 30, 2013 | -894,062.00 |
| Jun 30, 2013 | -786,321.00 |
| Jun 30, 2013 | -786,321.00 |
| Mar 31, 2013 | -756,950.00 |
| Mar 31, 2013 | -756,950.00 |
| Dec 31, 2012 | -574,367.00 |
| Dec 31, 2012 | -574,367.00 |
| Sep 30, 2012 | -938,629.00 |
| Sep 30, 2012 | -938,629.00 |
| Jun 30, 2012 | -652,613.00 |
| Jun 30, 2012 | -652,613.00 |
| Mar 31, 2012 | -818,075.00 |
| Mar 31, 2012 | -818,075.00 |
| Dec 31, 2011 | -483,263.00 |
| Dec 31, 2011 | -483,263.00 |
| Sep 30, 2011 | -548,881.00 |
| Sep 30, 2011 | -548,881.00 |
| Jun 30, 2011 | -642,637.00 |
| Jun 30, 2011 | -642,637.00 |
| Mar 31, 2011 | -593,143.00 |
| Mar 31, 2011 | -593,143.00 |
| Dec 31, 2010 | -678,459.00 |
| Dec 31, 2010 | -678,459.00 |
| Sep 30, 2010 | -642,167.00 |
| Sep 30, 2010 | -642,167.00 |